A similar analysis of Oncotype RS in a cohort of 269 patients with breast cancer also found that post-menopausal patients had higher RS and lower PR expression than pre-menopausal patients, which is consistent with the higher rates of PR negativity seen in our post-menopausal cohort [23]. This evidence concerns the gene PGR and breast cancer.